Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Improved longitudinal gray and white matter atrophy assessment via application of a 4-dimensional hidden Markov random field model.

Dwyer MG, Bergsland N, Zivadinov R.

Neuroimage. 2014 Apr 15;90:207-17. doi: 10.1016/j.neuroimage.2013.12.004. Epub 2013 Dec 12.

PMID:
24333394
2.

Development of gray matter atrophy in relapsing-remitting multiple sclerosis is not gender dependent: results of a 5-year follow-up study.

Dolezal O, Gabelic T, Horakova D, Bergsland N, Dwyer MG, Seidl Z, Krasensky J, Ramasamy DP, Vaneckova M, Havrdova E, Zivadinov R.

Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S42-8. doi: 10.1016/j.clineuro.2013.09.020.

PMID:
24321154
3.

Gray matter atrophy is related to long-term disability in multiple sclerosis.

Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, Thompson AJ, Miller DH.

Ann Neurol. 2008 Sep;64(3):247-54. doi: 10.1002/ana.21423. Erratum in: Ann Neurol. 2009 Feb;65(2):232.

PMID:
18570297
4.

White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.

Mühlau M, Buck D, Förschler A, Boucard CC, Arsic M, Schmidt P, Gaser C, Berthele A, Hoshi M, Jochim A, Kronsbein H, Zimmer C, Hemmer B, Ilg R.

Mult Scler. 2013 Oct;19(11):1485-92. doi: 10.1177/1352458513478673. Epub 2013 Mar 5.

PMID:
23462349
5.

Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.

Battaglini M, Giorgio A, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.

J Neurol Sci. 2009 Jul 15;282(1-2):55-60. doi: 10.1016/j.jns.2009.02.322. Epub 2009 Mar 16.

PMID:
19286193
6.

Evaluating and reducing the impact of white matter lesions on brain volume measurements.

Battaglini M, Jenkinson M, De Stefano N.

Hum Brain Mapp. 2012 Sep;33(9):2062-71. doi: 10.1002/hbm.21344. Epub 2011 Aug 31.

PMID:
21882300
7.

Gray matter atrophy in multiple sclerosis: a longitudinal study.

Fisher E, Lee JC, Nakamura K, Rudick RA.

Ann Neurol. 2008 Sep;64(3):255-65. doi: 10.1002/ana.21436.

PMID:
18661561
8.

Mapping regional grey and white matter atrophy in relapsing-remitting multiple sclerosis.

Riccitelli G, Rocca MA, Pagani E, Martinelli V, Radaelli M, Falini A, Comi G, Filippi M.

Mult Scler. 2012 Jul;18(7):1027-37. doi: 10.1177/1352458512439239. Epub 2012 Mar 15.

PMID:
22422807
9.

Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.

Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P.

Arch Neurol. 2009 Feb;66(2):173-9. doi: 10.1001/archneurol.2008.562.

PMID:
19204153
10.

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

Rudick RA, Lee JC, Nakamura K, Fisher E.

J Neurol Sci. 2009 Jul 15;282(1-2):106-11. doi: 10.1016/j.jns.2008.11.018. Epub 2008 Dec 19.

11.

Gray and white matter volume changes in early RRMS: a 2-year longitudinal study.

Tiberio M, Chard DT, Altmann DR, Davies G, Griffin CM, Rashid W, Sastre-Garriga J, Thompson AJ, Miller DH.

Neurology. 2005 Mar 22;64(6):1001-7.

PMID:
15781816
12.

Brain atrophy and lesion load in a large population of patients with multiple sclerosis.

Tedeschi G, Lavorgna L, Russo P, Prinster A, Dinacci D, Savettieri G, Quattrone A, Livrea P, Messina C, Reggio A, Bresciamorra V, Orefice G, Paciello M, Brunetti A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Patti F, Salemi G, Cammarata E, Simone IL, Salvatore M, Bonavita V, Alfano B.

Neurology. 2005 Jul 26;65(2):280-5.

PMID:
16043800
13.

The effect of hypointense white matter lesions on automated gray matter segmentation in multiple sclerosis.

Gelineau-Morel R, Tomassini V, Jenkinson M, Johansen-Berg H, Matthews PM, Palace J.

Hum Brain Mapp. 2012 Dec;33(12):2802-14. doi: 10.1002/hbm.21402. Epub 2011 Oct 5.

PMID:
21976406
14.

Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study.

Sastre-Garriga J, Ingle GT, Chard DT, Cercignani M, Ramió-Torrentà L, Miller DH, Thompson AJ.

Brain. 2005 Jun;128(Pt 6):1454-60. Epub 2005 Apr 7.

15.

Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.

Calabrese M, Agosta F, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, Bernardi V, Barachino L, Rinaldi L, Perini P, Gallo P, Filippi M.

Arch Neurol. 2009 Sep;66(9):1144-50. doi: 10.1001/archneurol.2009.174.

PMID:
19752305
16.

Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis.

Bendfeldt K, Kappos L, Radue EW, Borgwardt SJ.

J Neurol Sci. 2009 Oct 15;285(1-2):268-9; author reply 269. doi: 10.1016/j.jns.2009.05.020. Epub 2009 Jun 4. No abstract available.

PMID:
19500803
17.

Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study.

Horakova D, Dwyer MG, Havrdova E, Cox JL, Dolezal O, Bergsland N, Rimes B, Seidl Z, Vaneckova M, Zivadinov R.

J Neurol Sci. 2009 Jul 15;282(1-2):112-9. doi: 10.1016/j.jns.2008.12.005. Epub 2009 Jan 24.

PMID:
19168190
18.

Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.

Durand-Dubief F, Belaroussi B, Armspach JP, Dufour M, Roggerone S, Vukusic S, Hannoun S, Sappey-Marinier D, Confavreux C, Cotton F.

AJNR Am J Neuroradiol. 2012 Nov;33(10):1918-24. doi: 10.3174/ajnr.A3107. Epub 2012 Jul 12.

19.

Apolipoprotein E ε4-positive multiple sclerosis patients develop more gray-matter and whole-brain atrophy: a 15-year disease history model based on a 4-year longitudinal study.

Horáková D, Kýr M, Havrdová E, Doležal O, Lelková P, Pospíšilová L, Bergsland N, Dwyer MG, Cox JL, Hussein S, Seidl Z, Vaněčková M, Krásenský J, Zivadinov R.

Folia Biol (Praha). 2010;56(6):242-51.

20.

Segmentation of brain tissues using a 3-D multi-layer hidden Markov model.

Foruzan AH, Kalantari Khandani I, Baradaran Shokouhi S.

Comput Biol Med. 2013 Feb;43(2):121-30. doi: 10.1016/j.compbiomed.2012.11.001. Epub 2012 Dec 20.

PMID:
23261164
Items per page

Supplemental Content

Write to the Help Desk